Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram
CFO and Chief Corp. Dev. Off · Humacyte, Inc. · Common Stock
Open-market sale
$41K reported value · 14.7% of prior position
Disclosed 2 business days after execution (deadline: 2)
First recorded trade by this actor in this security
1 other actor traded the same direction within 14 days
No material company filing within 60 days after the trade
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Kuznik Paul BrianDirector | Grant or award | A | — 125.0K sh | Oct 7, 2026 traded Oct 6, 2026 | |
| 42 | Tommy TubervilleRJoint | Sale (Full) | SELL | $1,001 – $15K | Aug 5, 2026 traded May 3, 2024 | |
| 46 | Tommy TubervilleRJoint | Sale (Partial) | SELL | $15K – $50K | Aug 5, 2026 traded May 3, 2024 | |
| 39 | Tommy TubervilleRJoint | Purchase | BUY | $1,001 – $15K | Aug 5, 2026 traded Mar 21, 2024 | |
| 39 | Tommy TubervilleRJoint | Purchase | BUY | $1,001 – $15K | Aug 5, 2026 traded Mar 21, 2024 | |
| 43 | Tommy TubervilleRJoint | Purchase | BUY | $15K – $50K | Aug 5, 2026 traded Mar 21, 2024 | |
| 14 | Parikh Shamik JChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $41K 45.9K sh | May 20, 2026 traded May 18, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $41,147
Sander Dale A. filed this Form 4 reporting a open-market sale of HUMA on May 18, 2026. It became public on May 20, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.